U.S. flag

An official website of the United States government

NM_006158.5(NEFL):c.23C>G (p.Pro8Arg) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 14, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002426613.2

Allele description [Variation Report for NM_006158.5(NEFL):c.23C>G (p.Pro8Arg)]

NM_006158.5(NEFL):c.23C>G (p.Pro8Arg)

Gene:
NEFL:neurofilament light chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8p21.2
Genomic location:
Preferred name:
NM_006158.5(NEFL):c.23C>G (p.Pro8Arg)
HGVS:
  • NC_000008.11:g.24956493G>C
  • NG_008492.1:g.5125C>G
  • NM_006158.5:c.23C>GMANE SELECT
  • NP_006149.2:p.Pro8Arg
  • NP_006149.2:p.Pro8Arg
  • LRG_259t1:c.23C>G
  • LRG_259:g.5125C>G
  • LRG_259p1:p.Pro8Arg
  • NC_000008.10:g.24814007G>C
  • NM_006158.2:c.23C>G
  • NM_006158.3:c.23C>G
  • NM_006158.4:c.23C>G
  • P07196:p.Pro8Arg
Protein change:
P8R
Links:
UniProtKB: P07196#VAR_016020; dbSNP: rs61491953
NCBI 1000 Genomes Browser:
rs61491953
Molecular consequence:
  • NM_006158.5:c.23C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002731501Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Oct 14, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.

De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V.

Ann Neurol. 2001 Feb;49(2):245-9.

PubMed [citation]
PMID:
11220745

Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.

Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SCh, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V.

Brain. 2003 Mar;126(Pt 3):590-7.

PubMed [citation]
PMID:
12566280
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV002731501.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The p.P8R variant (also known as c.23C>G), located in coding exon 1 of the NEFL gene, results from a C to G substitution at nucleotide position 23. The proline at codon 8 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. This alteration has been reported in the heterozygous form in multiple affected individuals with Charcot-Marie-Tooth (CMT) disease, and was reported to occur de novo in one affected individual (Jordanova A et al. Brain, 2003 Mar;126:590-7; Miltenberger-Miltenyi G et al. Arch Neurol, 2007 Jul;64:966-70; Lin KP et al. PLoS One, 2011 Dec;6:e29393; Horga A et al. J Neurol Neurosurg Psychiatry, 2017 07;88:575-585). Functional studies have shown that this alteration has an effect on intermediate filament formation, resulting in mitochondrial and axonal abnormalities (Zhai J et al. Hum Mol Genet, 2007 Dec;16:3103-16; Tradewell ML et al. J Neuropathol Exp Neurol, 2009 Jun;68:642-52). The NEFL c.22_23delCCinsAG alteration, which results in an identical amino acid change, has been reported to segregate with disease in a family displaying autosomal dominant inheritance of CMT (De Jonghe P et al. Ann Neurol, 2001 Feb;49:245-9). Based on the supporting evidence, this variant is likely to be causative of autosomal dominant CMT, type 1F/2E; however, its clinical significance for autosomal recessive CMT, type 1F/2E is unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024